Orlando, FL – Last week at the 2022 PBMI Annual National Conference, Nicole Bulochnik, MS, PharmD, BCPS, BCCCP, CRC (Vice President of Drug Pricing and Network Strategy) and Timothy Mizak, PharmD, MS, MBA (Director of Drug Trend Solutions), presented on the topic of, “PBM-Payer Partnerships: Insights into Alternative Cost Management Strategies Across Common PBM Levers.” […]
Design Articles
PBM-Payer Partnerships: Insights into Alternative Cost Management Strategies
September 26th, 2022 by Abarca NewsAbarca’s financial model Assura receives PBMI Excellence Award for Cost Containment Strategies
September 15th, 2022 by GabrielleAventura, FL — Abarca, a pharmacy benefit manager (PBM) that is transforming the industry with a new approach to drug trend management and business practices, has been awarded the 2022 PBMI Excellence Award for Assura, the company’s innovative financial solution, from the Pharmacy Benefit Management Institute. “Assura gives health plans the ability to manage and […]
Long-Acting Insulin Biosimilars & Unbranded Biologics for the treatment of diabetes types 1 and 2
September 9th, 2022 by Abarca NewsWithin the treatment of diabetes, insulin is considered a standard of care and can be used to treat both type 1 and type 2. There are multiple types of insulins, one of which is glargine, a long-acting basal insulin. As of May 2022, there are five FDA-approved glargine products currently available on the market (Lantus, […]
Learn the difference between Anxiety versus Depression
September 7th, 2022 by Abarca NewsAnxiety and depression are types of mood disorders. Even though the two conditions are different, it is common for someone with an anxiety disorder to also suffer from depression or vice versa. Anxiety refers to the anticipation of a future concern and is associated with muscle tension and nervousness, whereas Depression can cause persistent feelings […]
Create Hope Through Action: Abarca goes all in to raise awareness of suicide prevention
September 1st, 2022 by Abarca NewsDid you know that 1 in every 100 deaths around the world is a result of suicide? Every death caused by suicide has a ripple effect of devastation and a deep impact on the people around them. The COVID-19 pandemic has contributed to increased feelings of isolation and vulnerability and, as hard as the subject […]
What you need to know: New CMS Basal Insulin measure
August 23rd, 2022 by GabrielleDiabetes affects more than 37 million U.S. adults and is the seventh leading cause of death in the country. Of that group, approximately 7.4 million rely on insulin to manage their condition. To help address this, the Centers for Medicare and Medicaid Services (CMS) released a new display measure in April, called Persistence to Basal […]
What You Should Know About Monkeypox
August 14th, 2022 by Abarca NewsSince the beginning of the summer, health authorities have been watching the development of the monkeypox outbreak which has spread through several countries where the disease is not normally reported, such as in the United States. As of Thursday, August 4, 2022, Health and Human Services Secretary, Xavier Becerra, declared the monkeypox outbreak a public […]
Protect yourself & loved ones against vaccine-preventable diseases
August 1st, 2022 by Abarca NewsNational Immunization Awareness Month (NIAM) is an annual observance held in August to highlight the benefits of vaccination for people of all ages. As part of our unrelenting commitment to providing a better way in healthcare, Abarca supports the importance of vaccines for disease prevention and building a culture of preparedness. Why vaccinate? Vaccines work […]
Abarca brings awareness to Viral Hepatitis: Hepatitis Can’t Wait
July 28th, 2022 by Abarca NewsEvery year, World Hepatitis Day represents an opportunity for communities worldwide to come together under a single theme to raise awareness of viral hepatitis. This year, the theme is ‘Hepatitis Can’t Wait’ Abarca calls on the healthcare community to take action and raise awareness to find the “missing millions” of people living with undiagnosed hepatitis […]
Listen to Jason Borschow’s interview on the PCMA podcast
July 14th, 2022 by GabrielleJason Borschow, Abarca’s president and CEO, was invited to be a guest on a recent episode of “The Pharmacy Benefit” a podcast from PCMA. The episode, “Competition in the PBM Marketplace,” featured a lively conversation between Jason, fellow guest Mike Ellis, CEO of Maxor, and host JC Scott, president, and CEO of PCMA. Among other […]